Zacks Research cut shares of Oxbridge Re (NASDAQ:OXBR – Free Report) from a hold rating to a strong sell rating in a research report released on Tuesday morning,Zacks.com reports.
A number of other research analysts have also recently issued reports on OXBR. Weiss Ratings raised Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a report on Friday, August 14th. Maxim Group lowered their target price on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating on the stock in a report on Tuesday, June 16th. One analyst has rated the stock with a Buy rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, Oxbridge Re presently has a consensus rating of “Reduce” and a consensus target price of $3.00.
Get Our Latest Stock Report on OXBR
Oxbridge Re Trading Down 0.7%
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its earnings results on Thursday, August 13th. The insurance provider reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). Oxbridge Re had a return on equity of 2.14% and a net margin of 4.71%.The company had revenue of $0.94 million for the quarter, compared to the consensus estimate of $1.10 million. On average, sell-side analysts forecast that Oxbridge Re will post -0.08 EPS for the current fiscal year.
Institutional Investors Weigh In On Oxbridge Re
Large investors have recently bought and sold shares of the business. Virtu Financial LLC bought a new position in Oxbridge Re in the 3rd quarter valued at $32,000. International Assets Investment Management LLC acquired a new position in Oxbridge Re in the fourth quarter worth $39,000. Finally, J.W. Cole Advisors Inc. grew its holdings in shares of Oxbridge Re by 106.1% during the fourth quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after purchasing an additional 35,000 shares during the last quarter. 5.64% of the stock is currently owned by institutional investors.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
See Also
- Five stocks we like better than Oxbridge Re
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
